- Clone
- B27 (See other available formats)
- Regulatory Status
- RUO
- Other Names
- Interferon-γ, Immune interferon, Type II interferon, T cell interferon, Macrophage-activating factor (MAF), IFN-g, IFN-gamma
- Isotype
- Mouse IgG1, κ
- Ave. Rating
- Submit a Review
- Product Citations
- publications
![B27_Purified_IFN-gamma_Antibody_012519_updated.png B27_Purified_IFN-gamma_Antibody_012519_updated.png](https://d1spbj2x7qk4bg.cloudfront.net/Admin/Public/GetImage.ashx?Image=/Files/Images/media_assets/products/product_images/B27_Purified_IFN-gamma_Antibody_012519_updated.png&Width=240&Height=300&altFmImage_path=&Compression=90&Crop=5)
-
PMA+ionomycin-stimulated human peripheral blood lymphocytes (6-hours), in the presence of monensin, were fixed, permeabilized, and then intracellularly stained with IFN-γ (clone B27) Purified (filled histogram), or mouse IgG1, κ PerCP/Cyanine5.5 isotype control (open histogram) followed by anti-mouse IgG FITC.
Select size of product is eligible for a 40% discount! Promotion valid until September 30, 2024. Exclusions apply. To view full promotion terms and conditions or to contact your local BioLegend representative to receive a quote, visit our webpage.
Interferon-γ is a potent multifunctional cytokine which is secreted primarily by activated NK cells and T cells. Originally characterized based on anti-viral activities, IFN-γ also exerts anti-proliferative, immunoregulatory, and proinflammatory activities. IFN-γ can upregulate MHC class I and II antigen expression by antigen-presenting cells. The B27 antibody reacts with the human interferon-γ. The B27 antibody can neutralize the bioactivity of natural or recombinant IFN-γ.
Product DetailsProduct Details
- Verified Reactivity
- Human
- Reported Reactivity
- Chimpanzee, Baboon, Cynomolgus, Rhesus, African Green, Pigtailed Macaque, Sooty Mangabey
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Immunogen
- E. coli-expressed recombinant human IFN-γ
- Formulation
- 0.2 µm filtered in phosphate-buffered solution, pH 7.2, containing no preservative.
- Endotoxin Level
- Less than 0.01 EU/µg of the protein (< 0.001 ng/µg of the protein) as determined by the LAL test.
- Preparation
- The Ultra-LEAF™ (Low Endotoxin, Azide-Free) antibody was purified by affinity chromatography.
- Concentration
- The antibody is bottled at the concentration indicated on the vial, typically between 2 mg/mL and 3 mg/mL. Older lots may have also been bottled at 1 mg/mL. To obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C. This Ultra-LEAF™ solution contains no preservative; handle under aseptic conditions.
- Application
-
ICFC - Quality tested
FC, Neut - Reported in the literature, not verified in house - Recommended Usage
-
Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
- Application Notes
-
Flow Cytometry2: The fluorochrome-labeled B27 antibody is useful for intracellular immunofluorescent staining and flow cytometric analysis to identify IFN-? -producing cells within mixed cell populations. For intracellular cytokine staining protocol, please visit www.biolegend.com and click on the support section.
Neutralization1,3,6,7: The Ultra-LEAF™ Purified antibody (Endotoxin <0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for neutralization of human IFN-? bioactivity (Cat. No. 506531). - Application References
-
- Favre C, et al. 1989. Molec. Immunol. 26:17. (Neut)
- Kaur A, et al. 2002. J Virol. 76:3646.
- Abrams J, et al. 1992. Immunol. Rev. 127:5. (Neut)
- Andersson U, et al. 1999. Detection and quantification of gene expression. New York:Springer-Verlag.
- Rout N, et al. 2010. PLoS One 5:e9787. (FC)
- Acosta-Rodriguez EV, et al. 2007. Nat. Immunol. 9:942-9. (Neut)
- Gangur V, et al. 1998. FASEB J. 12:705-13. (Neut)
- Product Citations
-
- RRID
-
AB_2801095 (BioLegend Cat. No. 506535)
AB_2801096 (BioLegend Cat. No. 506536)
AB_2801094 (BioLegend Cat. No. 506534)
AB_2801091 (BioLegend Cat. No. 506531)
AB_2801092 (BioLegend Cat. No. 506532)
AB_2801093 (BioLegend Cat. No. 506533)
Antigen Details
- Structure
- Cytokine; dimer; 20-25 kD (Mammalian)
- Bioactivity
- Antiviral/antiparasitic activities; inhibits proliferation; enhances MHC class I and II expression on APC
- Cell Sources
- CD8+ and CD4+ T cells, NK cells
- Cell Targets
- T cells, B cells, macrophages, NK cells, endothelial cells, fibroblasts
- Receptors
- IFN-γRα (CDw119) dimerized with IFN-γRβ (AF-1)
- Cell Type
- Tregs
- Biology Area
- Cell Biology, Immunology, Neuroinflammation, Neuroscience
- Molecular Family
- Cytokines/Chemokines
- Antigen References
-
1. Fitzgerald K, et al. Eds. 2001. The Cytokine FactsBook. Academic Press San Diego.
2. De Maeyer E, et al. 1992. Curr. Opin. Immunol. 4:321.
3. Farrar M, et al. 1993. Annu. Rev. Immunol. 11:571.
4. Gray P, et al. 1987. Lymphokines 13:151. - Regulation
- Upregulated by IL-2, FGF-basic, EGF; downregulated by vitamin D3 or DMN; labile at pH2
- Gene ID
- 3458 View all products for this Gene ID
- UniProt
- View information about IFN-gamma on UniProt.org
Related FAQs
- Do you guarantee that your antibodies are totally pathogen free?
-
BioLegend does not test for pathogens in-house aside from the GoInVivo™ product line. However, upon request, this can be tested on a custom basis with an outside, independent laboratory.
- Does BioLegend test each Ultra-LEAF™ antibody by functional assay?
-
No, BioLegend does not test Ultra-LEAF™ antibodies by functional assays unless otherwise indicated. Due to the possible complexities and variations of uses of biofunctional antibodies in different assays and because of the large product portfolio, BioLegend does not currently perform functional assays as a routine QC for the antibodies. However, we do provide references in which the antibodies were used for functional assays and we do perform QC to verify the specificity and quality of the antibody based on our strict specification criteria.
- Does BioLegend test each Ultra-LEAF™ antibody for potential pathogens?
-
No, BioLegend does not test for pathogens in-house unless otherwise indicated. However, we can recommend an outside vendor to perform this testing as needed.
- Have you tested this Ultra-LEAF™ antibody for in vivo or in vitro applications?
-
We don't test our antibodies for in vivo or in vitro applications unless otherwise indicated. Depending on the product, the TDS may describe literature supporting usage of a particular product for bioassay. It may be best to further consult the literature to find clone specific information.
Other Formats
View All IFN-γ Reagents Request Custom ConjugationDescription | Clone | Applications |
---|---|---|
APC anti-human IFN-γ | B27 | ICFC |
FITC anti-human IFN-γ | B27 | ICFC |
PE anti-human IFN-γ | B27 | ICFC |
Purified anti-human IFN-γ | B27 | ICFC,Neut,FC |
Alexa Fluor® 700 anti-human IFN-γ | B27 | ICFC |
PE/Cyanine7 anti-human IFN-γ | B27 | ICFC |
Purified anti-human IFN-γ (Maxpar® Ready) | B27 | ICFC,CyTOF® |
APC/Cyanine7 anti-human IFN-γ | B27 | ICFC |
Pacific Blue™ anti-human IFN-γ | B27 | ICFC |
PerCP/Cyanine5.5 anti-human IFN-γ | B27 | ICFC |
PE/Dazzle™ 594 anti-human IFN-γ | B27 | ICFC |
Ultra-LEAF™ Purified anti-human IFN-γ | B27 | ICFC,Neut,FC |
Brilliant Violet 605™ anti-human IFN-γ | B27 | ICFC |
Brilliant Violet 510™ anti-human IFN-γ | B27 | ICFC |
Brilliant Violet 421™ anti-human IFN-γ | B27 | ICFC |
TotalSeq™-B1003 anti-human IFN-γ | B27 | ICPG |
Brilliant Violet 650™ anti-human IFN-γ | B27 | ICFC |
Brilliant Violet 711™ anti-human IFN-γ | B27 | ICFC |
Brilliant Violet 750™ anti-human IFN-γ | B27 | ICFC |
Customers Also Purchased
Compare Data Across All Formats
This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.
-
APC anti-human IFN-γ
PMA+ionomycin-stimulated (6 hours) human peripheral blood ly... -
FITC anti-human IFN-γ
PMA+ionomycin-stimulated (6 hours) human peripheral blood ly... -
PE anti-human IFN-γ
PMA+ionomycin-stimulated (6 hours) human peripheral blood ly... -
Purified anti-human IFN-γ
PMA+ionomycin-stimulated human peripheral blood lymphocytes ... -
Alexa Fluor® 700 anti-human IFN-γ
PMA+ionomycin-stimulated (5 hours) human PBMCs surface stain... -
PE/Cyanine7 anti-human IFN-γ
PMA/ionomycin-stimulated (5 hours) human peripheral blood ly... -
Purified anti-human IFN-γ (Maxpar® Ready)
Human PBMCs were incubated for 6 hours in media alone (top) ... -
APC/Cyanine7 anti-human IFN-γ
PMA+ionomycin-stimulated (in the presence of monensin, 6hrs)... -
Pacific Blue™ anti-human IFN-γ
PMA+ionomycin-stimulated (in the presence of monensin, 6hrs)... -
PerCP/Cyanine5.5 anti-human IFN-γ
PMA+ionomycin-stimulated human peripheral blood lymphocytes... -
PE/Dazzle™ 594 anti-human IFN-γ
PMA+ionomycin-stimulated (in the presence of monensin, 6hrs)... -
Ultra-LEAF™ Purified anti-human IFN-γ
PMA+ionomycin-stimulated human peripheral blood lymphocytes ... -
Brilliant Violet 605™ anti-human IFN-γ
PMA+Ionomycin-stimulated (4 hours) human peripheral blood ly... -
Brilliant Violet 510™ anti-human IFN-γ
PMA+Ionomycin-stimulated (4 hours) human peripheral blood ly... -
Brilliant Violet 421™ anti-human IFN-γ
PMA+Ionomycin-stimulated (4 hours) human peripheral blood ly... -
TotalSeq™-B1003 anti-human IFN-γ
-
Brilliant Violet 650™ anti-human IFN-γ
Human peripheral blood lymphocytes were stimulated with Cell... -
Brilliant Violet 711™ anti-human IFN-γ
Human peripheral blood lymphocytes were stimulated with Cell... -
Brilliant Violet 750™ anti-human IFN-γ
Human peripheral blood mononuclear cells were stimulated wit...
Follow Us